| Cannabis Science, Inc. (OTCBB:CBIS.ob - News), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to report an overall corporate and operations guidance outlook as very positive for 2012. Cannabis Sciences' analysis of the worldwide market potential for its formulations for medical cannabis treatments of critical ailments include three main markets for distribution: FDA approved prescriptions, OTC Non-psychoactive nutraceuticals, and licensed dispensarie...continued CBIS |
Thursday, February 2, 2012
Cannabis Science Issues Corporate & Operations Guidance to Shareholders in Regards to Dividend, Market Potential, and Anecdotal Reports
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment